TI
ENTA icon

Trexquant Investment’s Enanta Pharmaceuticals ENTA Stock Holding History

Trexquant Investment’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$709K Buy
+56,167
New +$753K 0.01% 1346
2025
Q4 		– Sell
-127,363
Closed -$1.52M – 1670
2025
Q3 		$1.52M Sell
127,363
-137,595
-52% -$1.1M 0.02% 1011
2025
Q2 		$2M Sell
264,958
-25,101
-9% -$151K 0.02% 883
2025
Q1 		$1.6M Buy
290,059
+154,105
+113% +$952K 0.02% 939
2024
Q4 		$782K Buy
135,954
+67,040
+97% +$643K 0.01% 1177
2024
Q3 		$714K Sell
68,914
-10,009
-13% -$131K 0.01% 1160
2024
Q2 		$1.02M Sell
78,923
-16,716
-17% -$226K 0.02% 994
2024
Q1 		$1.67M Sell
95,639
-22,973
-19% -$304K 0.03% 714
2023
Q4 		$1.12M Sell
118,612
-13,949
-11% -$130K 0.03% 785
2023
Q3 		$1.48M Buy
+132,561
New +$2.14M 0.04% 597
2022
Q4 		– Sell
-4,882
Closed -$253K – 1460
2022
Q3 		$253K Sell
4,882
-1,370
-22% -$80K 0.01% 1099
2022
Q2 		$296K Buy
+6,252
New +$339K 0.01% 1126
2021
Q3 		– Sell
-7,958
Closed -$350K – 1228
2021
Q2 		$350K Buy
+7,958
New +$390K 0.03% 636
2021
Q1 		– Sell
-7,124
Closed -$300K – 1200
2020
Q4 		$300K Sell
7,124
-8,514
-54% -$375K 0.03% 689
2020
Q3 		$716K Buy
15,638
+7,802
+100% +$378K 0.05% 536
2020
Q2 		$393K Buy
+7,836
New +$406K 0.03% 767
2019
Q3 		– Sell
-3,824
Closed -$323K – 925
2019
Q2 		$323K Sell
3,824
-11,180
-75% -$1.01M 0.03% 580
2019
Q1 		$1.43M Buy
+15,004
New +$1.35M 0.1% 287
2018
Q3 		– Sell
-5,266
Closed -$610K – 1005
2018
Q2 		$610K Buy
+5,266
New +$525K 0.04% 486
2018
Q1 		– Sell
-8,620
Closed -$506K – 1154
2017
Q4 		$506K Buy
+8,620
New +$432K 0.06% 509

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Trexquant Investment's ENTA Position: Q1 2026 in Review

Trexquant Investment opened a new position in Enanta Pharmaceuticals (ENTA) in Q1 2026: 56,167 shares worth $709K. The stake represents 0.01% of the portfolio and ranks #1346 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in ENTA as recently as Q3 2025.

Trexquant Investment first reported a position in ENTA in Q4 2017 and has held it in 20 quarters since. The position peaked at $2M in Q2 2025. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Trexquant Investment held 56,167 shares of Enanta Pharmaceuticals worth $709K as of Q1 2026.
  • Enanta Pharmaceuticals was a new Trexquant Investment position in Q1 2026.
  • Enanta Pharmaceuticals made up 0.01% of Trexquant Investment's portfolio in Q1 2026, its #1346 holding.
  • Trexquant Investment first reported a position in Enanta Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
  • Trexquant Investment's Enanta Pharmaceuticals position peaked at $2M in Q2 2025.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.